ATRC 30.72 (+2.23%)
US04963C2098Medical Devices & InstrumentsMedical Instruments & Supplies

AtriCure (ATRC) Stock Highlights

30.72 | +2.23%
2024-12-21 03:41:51
AtriCure Inc is a innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

Statistics

Range Today
29.56 31.02
Volume Today 699.4K
Range 1 Year
18.94 39.05
Volume 1 Year 172.42M
Range 3 Year
18.94 74.85
Volume 3 Year 329.92M
Range 10 Year
13.44 89.18
Volume 10 Year 776.98M

Highlights

Market Capitalization 1.83B (small)
Floating Shares 47.09M
Current Price 30.72
Price To Earnings -44.96
Price To Revenue 3.95
Price To Book 3.93
Earnings Per Share -0.83
Payout Ratio 0%

Performance

Latest +2.23%
1 Month -15.16%
3 Months +7.11%
6 Months +43.48%
1 Year -14.36%
3 Years -53.94%
5 Years -0.19%
10 Years +60.08%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.